The organisation will use the funding to raise the profile of their organisation with health bodies such as the Department of Health, NHS and Medicines & Healthcare products Regulatory Agency. This will enable the organisation to increase the awareness of fetal anti-convulsant syndrome with health care professionals to ensure parents, patients and women with epilepsy that have been prescribed anti-convulsant medication are familiar with this condition.